Fengjiao Wang
-
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 5
- Cancer Genomics and Diagnostics 2
- Aquatic Science top 10%
-
- RNA modifications and cancer 8
- CRISPR and Genetic Engineering 3
- Peroxisome Proliferator-Activated Receptors 3
-
- Antibiotics Pharmacokinetics and Efficacy 3
-
- Biochemical effects in animals 2
- Co-authors
- Sue-min ChangJinfeng NingKaibin ZhuJianqun MaYaoguo LangShidong XuXiaoguang LiJunfeng Wang
- Journals
- Scientific Reports (2 papers)Journal of Biomedical Nanotechnology (2 papers)International Journal of Biological Sciences (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Fengjiao Wang
52 papers receiving 692 citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Cancer Research 130
- Aquatic Science 59
- Immunology 141
- Nephrology 39
- Molecular Biology 366
Countries citing papers authored by Fengjiao Wang
This map shows the geographic impact of Fengjiao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengjiao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengjiao Wang more than expected).
Fields of papers citing papers by Fengjiao Wang
This network shows the impact of papers produced by Fengjiao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengjiao Wang. The network helps show where Fengjiao Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fengjiao Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | Association of triglyceride glucose-related parameters with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999–2018breakdown → | 2024 | 43 |
| 5 | 2024 | 1 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 10 | |
| 11 | 2023 | 7 | |
| 12 | 2023 | 2 | |
| 13 | 2023 | 1 | |
| 14 | 2022 | 13 | |
| 15 | 2020 | 9 | |
| 16 | 2020 | 44 | |
| 17 | 2018 | 11 | |
| 18 | 2013 | 17 | |
| 19 | 2005 | 102 | |
| 20 | 2001 | 2 |
About Fengjiao Wang
Fengjiao Wang is a scholar working on Cancer Research, Business and International Management and Molecular Biology, having authored 58 papers that have together received 703 indexed citations. Recurring topics across this work include RNA modifications and cancer (8 papers), MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (5 papers), CRISPR and Genetic Engineering (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Biochemical effects in animals (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Cancer Research (130 citations), Aquatic Science (59 citations) and Immunology (141 citations). Fengjiao Wang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Sue-min Chang, Jinfeng Ning, Kaibin Zhu, Jianqun Ma, Yaoguo Lang, Shidong Xu, Xiaoguang Li, Junfeng Wang, Xiangyuan Jin and Fan Yang. Their work appears in journals such as Scientific Reports, Journal of Biomedical Nanotechnology, International Journal of Biological Sciences, Oncotarget and Microbiology Spectrum.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.